CoChat

Can a semi-quantitative method replace the current quantitative method for the annual screening of microalbuminuria in patients with diabetes? Diagnostic accuracy and cost-saving analysis considering the potential health burden

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Diabetes is a global epidemic, and the high cost of annually and quantitatively measuring urine albumin excretion using the turbidimetric immunoassay is challenging. We aimed to determine whether a semi-quantitative urinary albumin-creatinine ratio test could be used as a screening tool for microalbuminuria in diabetic patients. METHODS: We assessed the diagnostic accuracy of the semi-quantitative method. The costs of false results in the semi-quantitative method were calculated based on the annual probability of disease progression analyzed through a systematic literature review and meta-analysis. The pooled long-term cost-saving effect of the semi-quantitative method compared with the quantitative test was assessed using a Markov model simulating a long-term clinical setting. Diagnostic accuracy and the cost-saving effect were also validated in an independent external cohort. RESULTS: Compared with the quantitative test, the semi-quantitative method had sensitivities of 93.5% and 81.3% and specificities of 61.4% and 63.1% in the overall sample of diabetic patients (n = 1,881) and in diabetic patients with eGFR ≥60 ml/min/1.73 m2 and a negative dipstick test (n = 1,110), respectively. After adjusting for direct and indirect medical costs, including the risk of disease progression, which was adjusted by the meta-analyzed hazard ratio for clinical outcomes, it was determined that using the semi-quantitative method could save 439.4 USD per person for 10 years. Even after adjusting the result to the external validation cohort, 339.6 USD could be saved for one diabetic patient for 10 years. CONCLUSIONS: The semi-quantitative method could be an appropriate screening tool for albuminuria in diabetic patients. Moreover, it can minimize the testing time and inconvenience and significantly reduce national health costs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0227694

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Structure of the Markov model. The square denotes a decision node where the quantitative or semi-quantitative screening strategy can be chosen. The circles represent chance nodes in which subsequent events occur at probabilities allocated to each node. The letter M in a circle indicates a Markov node. The triangles represent terminal nodes, where subjects return to the Markov node from which they started the cycle and start the next cycle again. Descriptions accompanying terminal nodes designate the path for the subjects to follow at the next Markov cycle. * Annual probabilities of these clinical events were derived from diabetic patients with normo-albuminuria. ** Putatively, both true negative and false negative fractions are present in the SemiQ negative population. The occurrences from both cases were included. For the population with false negatives, the hazard ratio for clinical outcomes was assessed in micro- or overt albuminuric diabetic patients. Additionally, for the population with true negative results, the hazard ratio for clinical outcomes was assessed in normo-albuminuric diabetic patients. Abbreviations: CVD, cardiovascular disease; DM, diabetes mellitus; ESRD, end-stage renal disease.
Fig 1 Structure of the Markov model. The square denotes a decision node where the quantitative or semi-quantitative screening strategy can be chosen. The circles represent chance nodes in which subsequent events occur at probabilities allocated to each node. The letter M in a circle indicates a Markov node. The triangles represent terminal nodes, where subjects return to the Markov node from which they started the cycle and start the next cycle again. Descriptions accompanying terminal nodes designate the path for the subjects to follow at the next Markov cycle. * Annual probabilities of these clinical events were derived from diabetic patients with normo-albuminuria. ** Putatively, both true negative and false negative fractions are present in the SemiQ negative population. The occurrences from both cases were included. For the population with false negatives, the hazard ratio for clinical outcomes was assessed in micro- or overt albuminuric diabetic patients. Additionally, for the population with true negative results, the hazard ratio for clinical outcomes was assessed in normo-albuminuric diabetic patients. Abbreviations: CVD, cardiovascular disease; DM, diabetes mellitus; ESRD, end-stage renal disease.CC BY · PubMed Central
Fig 2 Relative hazard ratios for major clinical outcomes such as death, cardiovascular disease, and end-stage renal disease in diabetic patients with albuminuria and eGFR ≥60 ml/min/1.73 m2 compared to normo-albuminuric diabetic patients. Abbreviations: CVD, cardiovascular disease; CI, confidence interval; ESRD, end-stage renal disease; HR, hazard ratio.
Fig 2 Relative hazard ratios for major clinical outcomes such as death, cardiovascular disease, and end-stage renal disease in diabetic patients with albuminuria and eGFR ≥60 ml/min/1.73 m2 compared to normo-albuminuric diabetic patients. Abbreviations: CVD, cardiovascular disease; CI, confidence interval; ESRD, end-stage renal disease; HR, hazard ratio.CC BY · PubMed Central
Fig 3 Tornado diagram of one-way sensitivity analyses. The vertical dashed line indicates the value in the base case analysis. Black bars represent the deviation resulting from the increase in corresponding input values. Gray bars represent the deviation resulting from the decrease in corresponding input values. * Incidences of clinical outcomes were converted to annual probabilities in the Markov model. ** Hazard ratios for clinical outcomes among diabetic patients (micro-or overt albuminuria versus normo-albuminuria). The values were used to calculate incidences of clinical outcomes in diabetic patients with micro- or overt albuminuria. Abbreviations: CVD, cardiovascular disease; ESRD, end-stage renal disease; HR, hazard ratio; Q test, quantitative test; SemiQ test, semi-quantitative test.
Fig 3 Tornado diagram of one-way sensitivity analyses. The vertical dashed line indicates the value in the base case analysis. Black bars represent the deviation resulting from the increase in corresponding input values. Gray bars represent the deviation resulting from the decrease in corresponding input values. * Incidences of clinical outcomes were converted to annual probabilities in the Markov model. ** Hazard ratios for clinical outcomes among diabetic patients (micro-or overt albuminuria versus normo-albuminuria). The values were used to calculate incidences of clinical outcomes in diabetic patients with micro- or overt albuminuria. Abbreviations: CVD, cardiovascular disease; ESRD, end-stage renal disease; HR, hazard ratio; Q test, quantitative test; SemiQ test, semi-quantitative test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 2

  1. Tholen DW, Kallner A, Kennedy JW, Krouwer JS, Meier K. Evaluation of precision performance of quantitative measurement methods; approved guideline—second edition. Evaluation. 2004; 24(25).
  2. Ahn JH, Kim YH, Shin SJ, JY P. Cost of Medical Decision Making—Asian Joint Research on Effectiveness. National Evidence-based Healthcare Collaborating Agency; 2012.

Cited by

Metadata

Authors
Kim, Y., Park, S., Kim, M.-H., Song, S. H., Lee, W. M., Kim, H. S., Jin, K., Han, S., Kim, Y. C., Han, S. S., Lee, H., Lee, J. P., Joo, K. W., Lim, C. S., Kim, Y. S., & Kim, D. K.
Affiliations
  • Seoul National University (KR)
  • Eulji University (KR)
  • Keimyung University (KR)
Corresponding author
Kim, Dong Ki
Venue
PLOS ONE
Published
2020-01-21
Volume
15
Issue
1
Pages
e0227694
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3001164618
Cited by
12
References
47
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 1
FWCI
0.63
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
Ministry of Health and Welfare (HI17C0530)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
microalbuminuria, diabetes mellitus, urinary albumin-creatinine ratio, diabetic nephropathy screening, diagnostic accuracy, cost saving, disease progression, Markov model
MeSH terms
Albuminuria, Diabetes Mellitus, Diabetic Nephropathies, Humans, Mass Screening, Reproducibility of Results, Cohort Studies, Urinalysis, Cost Savings, Republic of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.